Exclusive: Protuoso gets $9.5M to build the next hub-and-spoke antibody developernews2026-05-26T13:17:51+00:00May 26th, 2026|Endpoints News|
Lilly to acquire three vaccine biotechs for up to $3.8Bnews2026-05-26T11:20:08+00:00May 26th, 2026|Endpoints News|
Astellas’ five-year plan includes chasing record sales and cost cutsnews2026-05-26T11:10:04+00:00May 26th, 2026|Endpoints News|
Lilly reports new data on PCSK9 base editing gene therapy from Verve buyoutnews2026-05-26T10:57:53+00:00May 26th, 2026|Endpoints News|
Adtech company Swoop buys pharmacy startup NimbleRx news2026-05-26T10:00:55+00:00May 26th, 2026|Endpoints News|
Inside Makary’s ouster; Another win for Lilly’s triple-G; and morenews2026-05-23T10:00:21+00:00May 23rd, 2026|Endpoints News|
FDA clears Gilead’s hepatitis D drug, four years after prior rejectionnews2026-05-22T18:35:28+00:00May 22nd, 2026|Endpoints News|
GOP lawmaker asks Trump administration to curb China biotech dealsnews2026-05-22T17:50:05+00:00May 22nd, 2026|Endpoints News|
AstraZeneca wins EU backing for breast cancer drug, splitting with FDA panel news2026-05-22T16:47:59+00:00May 22nd, 2026|Endpoints News|
How Utah’s AI prescribing experiment is going so farnews2026-05-22T16:25:02+00:00May 22nd, 2026|Endpoints News|
